Keyphrases
Pediatric Patients
100%
Response to Treatment
100%
Excellent Response
100%
Systemic Lupus Erythematosus
100%
Hydroxychloroquine
100%
Immune Thrombocytopenia
100%
Platelet Count
40%
Antinuclear Antibodies
20%
Immunofluorescence
10%
Classification Criteria
10%
Routine Screening
10%
Patients Included
10%
No Adverse Effect
10%
Antibody Titer
10%
Partial Response
10%
Adolescent Patients
10%
Immunomodulatory Drugs (IMiDs)
10%
Count Response
10%
Systemic Autoimmune Disorders
10%
European League against Rheumatism (EULAR)
10%
Pediatric Immune Thrombocytopenia
10%
Medicine and Dentistry
Pediatrics Patient
100%
Idiopathic Thrombocytopenic Purpura
100%
Systemic Lupus Erythematosus
100%
Hydroxychloroquine
100%
Platelet
40%
Antinuclear Antibody
20%
Pediatrics
10%
Retrospective Study
10%
Autoimmune Disease
10%
Immunofluorescence
10%
Immunomodulatory Drug
10%
Adverse Effect
10%
Immunology and Microbiology
Systemic Lupus Erythematosus
100%
Idiopathic Thrombocytopenic Purpura
100%
Hydroxychloroquine
100%
Platelet Count
40%
Antinuclear Antibody
20%
Immunofluorescence
10%
Autoimmune Disease
10%
Antibody Titer
10%
Immunomodulatory Drug
10%
Pharmacology, Toxicology and Pharmaceutical Science
Idiopathic Thrombocytopenic Purpura
100%
Systemic Lupus Erythematosus
100%
Hydroxychloroquine
100%
Antinuclear Antibody
20%
Retrospective Study
10%
Autoimmune Disease
10%